newdrugapprovals.org
FDA approves Avastin to treat patients with aggressive and late-stage cervical cancer
August 14, 2014The U.S. Food and Drug Administration today approved a new use for Avastin (bevacizumab) to treat patients with persistent, recurrent or late-stage (metastatic) cervical cancer.Cervi…